Bottom line
SHSSX vs BHCHX: the short answer
SHSSX (Blackrock Health Sciences Opportunities Portfolio) and BHCHX (Baron Health Care Fund) share a meaningful slice of their top holdings — about 54% by weight.
But SHSSX is far broader, holding 155 positions to 43 for BHCHX, so beyond the top names it adds exposure BHCHX doesn't have.
BHCHX is cheaper at 0.85% vs 0.86% — a difference of $1.00 a year per $10,000 invested.
Over five years, SHSSX returned +5.9% a year vs +2.8% for BHCHX.
Updated Nov 19, 2026
SHSSX vs BHCHX side by side
| SHSSX | BHCHX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | BlackRock | Baron Select |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.86% | 0.85% |
| Annual cost per $10k | $86 | $85 |
| 10-yr cost on $10k (prospectus) | $1,061 | $1,049 |
| Max front load | 0% | — |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +16.3% | +10.3% |
| 5-yr return (annualized) | +5.9% | +2.8% |
| 10-yr return (annualized) | +9.8% | — |
| Best quarter | — | — |
| Worst quarter | — | — |
| Net assets (fund) | $5.9B | $114.1M |
| Number of holdings | 155 | 43 |
| Portfolio turnover | 49% | 74% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
14 of SHSSX's top 25 holdings also appear in BHCHX's top 25.
| Holding | SHSSX | BHCHX |
|---|---|---|
| Eli Lilly & Company | 12.29% | 13.66% |
| Johnson & Johnson | 8.77% | 5.56% |
| Unitedhealth Group Inc | 6.10% | 3.28% |
| Merck & Company Inc | 4.94% | 2.48% |
| Gilead Sciences Inc | 4.19% | 1.99% |
| Thermo Fisher Scientific Inc | 3.02% | 3.91% |
| Vertex Pharmaceuticals Inc | 2.74% | 2.61% |
| Edwards Lifesciences Corp | 2.51% | 2.64% |
| Intuitive Surgical Inc | 1.95% | 1.74% |
| Teva Pharmaceutical Industries Ltd | 1.87% | 3.86% |
| Elevance Health Inc | 1.56% | 1.69% |
| Argenx Se | 1.26% | 4.23% |
| Astrazeneca Plc | 1.21% | 2.49% |
| Revolution Medicines Inc | 0.96% | 2.05% |
Source: SEC Form N-PORT
SHSSX top 10
- Eli Lilly & Company — 12.29%
- Johnson & Johnson — 8.77%
- Unitedhealth Group Inc — 6.10%
- Merck & Company Inc — 4.94%
- Gilead Sciences Inc — 4.19%
- Abbvie Inc — 3.94%
- Amgen Inc — 3.37%
- Thermo Fisher Scientific Inc — 3.02%
- Vertex Pharmaceuticals Inc — 2.74%
- Pfizer Inc — 2.61%
BHCHX top 10
- Eli Lilly & Co — 13.66%
- Mettler-Toledo International Inc — 5.60%
- Johnson & Johnson — 5.56%
- Argenx SE — 4.23%
- Thermo Fisher Scientific Inc — 3.91%
- Roivant Sciences Ltd — 3.88%
- Teva Pharmaceutical Industries Ltd — 3.86%
- Welltower Inc — 3.38%
- UnitedHealth Group Inc — 3.28%
- RadNet Inc — 3.24%
FAQ
What is the difference between SHSSX and BHCHX?
Which is cheaper, SHSSX or BHCHX?
Should I own both SHSSX and BHCHX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.